Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Yen Bai Pharmaceutical Joint Stock Company, known as YPHARCO, is a Vietnamese pharmaceutical manufacturer specializing in traditional herbal medicines and western pharmaceuticals. Established in 1966 and headquartered in Yen Bai Province, the company is most famous for its flagship product, Cam Xuyen Huong, a widely used herbal remedy for respiratory conditions. YPHARCO operates manufacturing facilities that comply with WHO-GMP standards, producing a range of dosage forms including tablets, capsules, and syrups. The company serves the domestic Vietnamese market through an extensive distribution network and is listed on the UPCoM stock exchange. Its portfolio focuses on respiratory health, gastrointestinal support, and musculoskeletal relief. The company has transitioned from a state-owned enterprise to a joint-stock model, maintaining a strong reputation for quality in traditional medicine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Yen Bai Pharmaceutical.